Limited 60% SUT Global Company Limited Purpose To increase company competitiveness in accordance to construction project bidding and operating Timing of Establishment Within 4th Quarter of 2017 2 เลขที่ 1
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 3rd quarter of 2017. The MD&A would enable the
Limited or “SORKON” and its subsidiaries (“the company”) would like to clarify the operating results for Quarter 3/2017 as following: Revenue and Net Sales The company recorded its total revenue of Baht
subsidiary company has no operating results yet for three-month period and nine-month period ended 30 September 2017. Please be informed accordingly. Sincerely yours, (Mr. Tradsin Chongussayakul) Chief
represented the Company’s book value per share at 17.61 and debt to equity ratio (D/E ratio) at 0.34 times. Cash Flow As at December 31, 2017, the Company had cash received from the operating activities around
, trade mark “Wuttisak Clinic” of which revenue sharing shall be made as follows Revenue Sharing HHC’ s Revenue gained from operating medical service for healthcare & esthetics = 100% HHC = 90% WCIG = 10
“SORKON” and its subsidiaries (“the company”) would like to clarify the operating results for Year 2017 as following: Revenue and Net Sales The company recorded its total revenue of Baht 2,776.7 million, or
46 (82) 883 n/a n/a 219 859 292% Net profit (loss) after NCI (40) (54) 654 n/a n/a 170 572 236% Performance without non-operating items 1 EBITDA 337 152 148 (3%) (56%) 797 753 (6%) 4Q17 % QoQ % YoY
Consolidated Financial Statements ended 31 December 2017, which have been audited by the Company’s authorized auditor. The company would like to clarify the operating results of the Company and its subsidiary
Plc. (“the Company”) would like to summarize it’s for the year 2017 operating performance for the period ending 31 December 2017 as follows: The Company and its subsidiaries’ posted a net profit of THB